FLORASUN ORTHOSIPHON CAP 250MG DIN 02051958
Health Canada record
| Active ingredient(s) | ORTHOSIPHON LEAF 250 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1994 |
| Current status date | 01-Aug-2000 |
| Source | Health Canada DPD |
Establishment licence of the holder
Laboratoire Riva Inc. — licence 100179, currently licensed, last inspection rating C (2026-01-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ORTHOSIPHON LEAF
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00442984 | HERMES 7 | HILARY'S DISTIBUTION LTD. | Tea (Herbal) | ORTHOSIPHON LEAF 13 %; UVA URSI 15 %; HERNIARIA 10 %; SCOURING RUSH 11 %; ONONIS SPINOSA 6 %; RHUS AROMATICA 5 %; ANGELICA 5 % | Cancelled Post Market |
| 02228025 | RETENTION D'EAU - CAP 250MG | LABORATOIRE LALCO INC. | Capsule | ORTHOSIPHON LEAF 250 MG | Cancelled Post Market |